CervoMed
CRVO
14 hedge funds and large institutions have $1.77M invested in CervoMed in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
7% less funds holding
Funds holding: 15 → 14 (-1)
16% less capital invested
Capital invested by funds: $2.1M → $1.77M (-$330K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$34.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$21.9K |
| 3 |
VF
Virtu Financial
New York
|
+$14.8K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.28K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRCM
Swift Run Capital Management
Charlottesville,
Virginia
|
-$49.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11.8K |
| 3 |
BlackRock
New York
|
-$9K |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$2K |
| 5 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$1K |
CRVO Hedge Fund Activity: Q2 2018 in Review
14 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2018, worth a combined $1.77M — down 16% from $2.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CRVO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $34.3K. The largest seller was Swift Run Capital Management, cutting an estimated $49.7K.
- 14 institutional investors held CervoMed (CRVO) as of Q2 2018, down from 15 in Q1 2018.
- Funds reported $1.77M of CervoMed stock for Q2 2018, down 16% quarter-over-quarter.
- 2 funds opened new CervoMed positions in Q2 2018 and 3 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q2 2018 was Renaissance Technologies, an estimated $34.3K added.
- The largest CervoMed seller in Q2 2018 was Swift Run Capital Management, an estimated $49.7K sold.
Based on aggregated 13F filings for Q2 2018.